ERYTHROPLAKIA
Clinical trials for ERYTHROPLAKIA explained in plain language.
Never miss a new study
Get alerted when new ERYTHROPLAKIA trials appear
Sign up with your email to follow new studies for ERYTHROPLAKIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Glow-in-the-Dark mouth scans could catch cancer early
Diagnosis OngoingThis study tests whether special lights and cameras can help find early signs of mouth cancer in people at high risk. Participants include those with mouth spots (leukoplakia, erythroplakia), a history of head and neck cancer, or conditions like Fanconi anemia or heavy tobacco us…
Matched conditions: ERYTHROPLAKIA
Phase: NA • Sponsor: M.D. Anderson Cancer Center • Aim: Diagnosis
Last updated May 22, 2026 14:04 UTC
-
Diabetes drug metformin shows promise in stopping oral cancer before it starts
Prevention OngoingThis study tests whether metformin, a drug used for diabetes, can prevent oral cancer in people with precancerous mouth lesions like leukoplakia or erythroplakia. About 26 participants took metformin to see if it could shrink or eliminate these lesions. The goal is to stop cancer…
Matched conditions: ERYTHROPLAKIA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Prevention
Last updated May 26, 2026 11:15 UTC
-
Can a diabetes drug stop oral cancer before it starts?
Prevention OngoingThis study tests whether metformin, a common diabetes drug, can prevent oral cancer in people with precancerous white or red patches in the mouth. 34 adults with these patches took metformin to see if it could reverse or stop the growth of abnormal cells. The goal is to find a sa…
Matched conditions: ERYTHROPLAKIA
Phase: PHASE2 • Sponsor: University of Arizona • Aim: Prevention
Last updated May 22, 2026 14:01 UTC